Sacubitril/valsartan reduces ventrucular arrhythmias in heart failure with reduced ejection fraction

被引：0
|
作者：
Lamaida, Norman [1 ]
Torella, Giorgio [1 ]
Cerciello, Antonio [1 ]
机构：
[1] Unita Operat Cardiol Clin Trusso Ottaviano, Ottaviano, Italy
来源：
EUROPEAN HEART JOURNAL SUPPLEMENTS | 2020年 / 22卷 / 0N期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
242
引用
收藏
页码：N26 / N26
页数：1
相关论文
共 50 条
  • [21] Focused Treatment of Heart Failure with Reduced Ejection Fraction Using Sacubitril/Valsartan
    Liu, Rex C.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2018, 18 (06) : 473 - 482
  • [22] Left Ventricular Ejection Fraction Recovery in Patients with Heart Failure and Reduced Ejection Fraction Treated with Sacubitril/Valsartan
    Diez-Villanueva, Pablo
    Vicent, Lourdes
    de la Cuerda, Francisco
    Esteban-Fernandez, Alberto
    Gomez-Bueno, Manuel
    de Juan-Baguda, Javier
    Manuel Iniesta, Angel
    Ayesta, Ana
    Rojas-Gonzalez, Antonio
    Bover-Freire, Ramon
    Iglesias, Diego
    Garcia-Aguado, Marcos
    Angel Perea-Egido, Jesus
    Salamanca, Jorge
    Martinez-Selles, Manuel
    CARDIOLOGY, 2020, 145 (05) : 275 - 282
  • [23] Impact of sacubitril/valsartan treatment on depression and anxiety in heart failure with reduced ejection fraction
    Dereli, Seckin
    Kilincel, Oguzhan
    Cerik, Idris Bugra
    Kaya, Ahmet
    ACTA CARDIOLOGICA, 2020, 75 (08) : 774 - 782
  • [24] Outcomes with sacubitril/valsartan in outpatients with heart failure and reduced ejection fraction: The ARIADNE registry
    Maggioni, Aldo P.
    Clark, Andrew L.
    Barrios, Vivencio
    Damy, Thibaud
    Drozdz, Jaroslaw
    Fonseca, Candida
    Lund, Lars H.
    Kalus, Stefanie
    Ferber, Philippe C.
    Hussain, Rizwan, I
    Koch, Cornelia
    Zeymer, Uwe
    ESC HEART FAILURE, 2022, 9 (06): : 4209 - 4218
  • [25] Efficacy and tolerability of sacubitril/valsartan in patients with chronic heart failure and reduced ejection fraction
    Cerciello, Antonio
    Lamaida, Norman
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [26] Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context
    D'Angiolella, Lucia S.
    Cortesi, Paolo A.
    Pitotti, Claudia
    Ritrovato, Daniela
    Mantovani, Lorenzo G.
    Senni, Michele
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 (11) : 1551 - 1553
  • [27] COST-EFFECTIVENESS OF SACUBITRIL/VALSARTAN IN HEART FAILURE WITH REDUCED EJECTION FRACTION IN SWEDEN
    Costa-Scharplatz, M.
    Lang, A.
    McMurray, J. J.
    Woodcock, F.
    Haroun, R.
    Johansson, D.
    Lund, L. H.
    VALUE IN HEALTH, 2016, 19 (07) : A650 - A651
  • [28] The reverse remodeling response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Martens, Pieter
    Belien, Hanne
    Dupont, Matthias
    Vandervoort, Pieter
    Mullens, Wilfried
    CARDIOVASCULAR THERAPEUTICS, 2018, 36 (04)
  • [29] Impact of Sacubitril/Valsartan on Lipid Parameters in Patients with Heart Failure with Reduced Ejection Fraction
    Hasan Ali Barman
    Selim Tanyolaç
    Omer Dogan
    Erdem Bal
    Adem Atıcı
    Serhan Özyıldırım
    Zerrin Yiğit
    Clinical Drug Investigation, 2022, 42 : 533 - 540
  • [30] Electrocardiographic predictors of response to sacubitril/valsartan therapy in heart failure with reduced ejection fraction
    Shpigelman, Jonathan
    Blaine, Ciara
    Nugent, Carol-Ann
    Kiernan, Louise
    Cahir, Caitriona
    Mac Curtain, Benjamin
    Bachari, Amir
    Irfan, Wadeed
    O'Boyle, Patrick
    O'Neill, James
    Daly, Michael
    JOURNAL OF ELECTROCARDIOLOGY, 2024, 84 : 104 - 108
12345